CD14 and neoplasm: Lastly, tumor-associated moDC are derived from Ly6C+ (mice) or CD14+ (humans) monocytes and are characterized as CD11c+ MHC-II+ F4/80− CD64+ in mice and CD14+, sometimes CD16+ in humans (64, 65).